Skip to main content
Clinical Trials/NL-OMON50343
NL-OMON50343CompletedNot Applicable

Insufficient cellular oxygen in ICU patients with anaemia: the INOX ICU-2 Study - the INOX ICU-2 Study

eids Universitair Medisch Centrum0 sites209 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
209

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • During the pilot study: all adult patients, admitted to the intensive care unit
  • with [Hb] below 6,3 mmol/l, who are planned to undergo a transfusion of red
  • blood cells.
  • During the prospective cohort study: all patients with a Hb below 6.3 mmol/l in
  • whom an arterial catheter is in place and in whom a red cell transfusion is

Exclusion Criteria

  • -adults without an legal representative for the informed consent,
  • -less than 18 years old,
  • -patients in need of emergency red cell transfusion e.g. bleeding,
  • -porphyria,
  • -known photodermatosis,
  • -ICU stay <24hrs,
  • -pregnant or breast feeding women since there is no adequate data from the use
  • of ALA in pregnant or breast feeding women,
  • -hypersensitivity to the active substance or to the plaster material of ALA,
  • -insufficient comprehensibility of the Dutch language

Investigators

Similar Trials